Ab Studio Inc.
- Home
- Companies
- Ab Studio Inc.
- Articles
- ABS-INT-001 Internalizing Ab-ADC for ...
ABS-INT-001 Internalizing Ab-ADC for Cancer Therapeutics - Case Study
Feb. 13, 2023
Courtesy ofAb Studio Inc.
Background
- Growth factor X is a well-characterized target that is involved in multiple proliferation-related signal transduction pathways
- Growth factor X expressed in multiple cancer types and therefore is an ideal target cancer therapies
Most popular related searches